StockData
Evommune, Inc. logo

Evommune, Inc. (EVMN) stock

EVMNNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$7.10−0.53 (-6.95%)

Close on Nov 16, 2026Market cap $257.67MP/E –Yield –

Evommune enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Evommune's enterprise value was $111.96M on Nov 11, 2026, against -$43.86M a year earlier.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$111.96M–
2025Dec 31, 2025-$49.44M–

More Evommune figures

See a number that looks wrong?